<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01951430</url>
  </required_header>
  <id_info>
    <org_study_id>MDS0413</org_study_id>
    <nct_id>NCT01951430</nct_id>
  </id_info>
  <brief_title>Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients</brief_title>
  <official_title>Observational Prospective Multicenter Study to Evaluate the Infective Risk in Myelodysplastic Syndrome Patients: Antimicrobial Prophylaxis and Granulocyte Growth Factors.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gruppo Italiano Malattie EMatologiche dell'Adulto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gruppo Italiano Malattie EMatologiche dell'Adulto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to observe the number of new cases of infections per population
      in a given time period and their characteristics in a pathology (myelodysplastic syndrome,
      MDS)that involves ineffective production (or dysplasia) of a class of blood cells.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The scarcity and the inadequacy of data make impossible the writing of evidence-based
      recommendations for prevention and management of infections in myelodysplastic syndrome.

      The aim of this study is to evaluate the incidence and the spectrum of the infections of MDS
      patients. Will be also evaluated potential risk factors.

      This study could help the definition of the optimal management of MDS patients in terms of
      prophylaxis of the infective complications and in terms of the correct administration of
      growth factors.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of infectious events in myelodysplastic syndrome patients</measure>
    <time_frame>at 1 year from study entry</time_frame>
    <description>Infectious events are fungal and antibiotic events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of MDS patients with a febrile event treated with antibiotic, antifungal and antiviral therapy</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of neutropenia</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who recover from infection</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients recovered from infection out of the total of patients with documented infection during the observational period</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who don't develop bacterial infection</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patient who don't develop fungal infection</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patient who don't develop viral infection</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients that needed granulocyte growth factors</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients that needed iron sequestrating therapy caused by iron overload</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of the hospitalization</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weeks of MDS suspension treatment</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients responding to therapy according to the administered treatment</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of MDS patients alive</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients without MDS progression</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for hospitalization</measure>
    <time_frame>at 1 year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level transfusion dependence</measure>
    <time_frame>At one year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of MDS subtype</measure>
    <time_frame>At one year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of risk of International Prognostic Scoring System (IPSS)</measure>
    <time_frame>At one year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of International Prognostic Scoring System (IPSS)-revised</measure>
    <time_frame>At one year from study entry</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of iron overload</measure>
    <time_frame>At one year from study entry.</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Myelodysplastic Syndrome</condition>
  <arm_group>
    <arm_group_label>Myelodysplastic syndrome patients</arm_group_label>
    <description>Patients affected by myelodysplastic syndrome enrolled in the observational study</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antibiotic and antifungal drugs</intervention_name>
    <arm_group_label>Myelodysplastic syndrome patients</arm_group_label>
    <other_name>levofloxacine;</other_name>
    <other_name>cyprofloxacine;</other_name>
    <other_name>co-trimoxazole;</other_name>
    <other_name>chinolones;</other_name>
    <other_name>cephalosporins;</other_name>
    <other_name>penicillines;</other_name>
    <other_name>other betalactams;</other_name>
    <other_name>macrolids;</other_name>
    <other_name>posaconazole;</other_name>
    <other_name>fluconazole;</other_name>
    <other_name>itraconazole.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult myelodysplastic syndrome patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult patients (&gt;18 years) with newly diagnosed myelodysplastic syndrome or
             patients who have undergone a bone marrow reevaluation;

          -  Signed written informed consent;

        Exclusion Criteria:

          -  Psychiatric patients;

          -  Patients with life expectancy less than three months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Livio Pagano, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università Cattolica del Sacro Cuore - Policlinico A. Gemelli - Roma</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paola Fazi, Dr.</last_name>
    <email>p.fazi@gimema.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Enrico Crea</last_name>
    <email>e.crea@gimema.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo</name>
      <address>
        <city>Alessandria</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Pietrasanta</last_name>
    </contact>
    <investigator>
      <last_name>Daniela Pietrasanta, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorella De Paoli, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera - Nuovo Ospedale 'Torrette'</name>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonella Poloni</last_name>
    </contact>
    <investigator>
      <last_name>Antonella Poloni, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benedetta Costantini, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giorgina Specchia</last_name>
    </contact>
    <investigator>
      <last_name>Giorgina Specchia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Divisione di Ematologia Ospedale A. Perrin</name>
      <address>
        <city>Brindisi</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Melpignano</last_name>
    </contact>
    <investigator>
      <last_name>Angela Melpignano</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gianluca Guaragna</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASL N.8 - Ospedale &quot;A. Businco&quot; - Struttura Complessa di Ematologia e CTMO</name>
      <address>
        <city>Cagliari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Angela Di Tucci</last_name>
    </contact>
    <investigator>
      <last_name>Anna Angela Di Tucci, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Graziella Pilo, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico di Careggi</name>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valeria Santini</last_name>
    </contact>
    <investigator>
      <last_name>Valeria Santini</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alessandro Sanna</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Gobbi</last_name>
    </contact>
    <investigator>
      <last_name>Marco Gobbi</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maurizio Miglino</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE</name>
      <address>
        <city>Lecce</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Di Renzo</last_name>
    </contact>
    <investigator>
      <last_name>Nicola Di Renzo</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valentina Vezzoli</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria - Università degli Studi di Napoli &quot;Federico II&quot; - Facoltà di Medicina e Chirurgia</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrizio Pane</last_name>
    </contact>
    <investigator>
      <last_name>Fabrizio Pane</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giuseppe Cerciello</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro</name>
      <address>
        <city>Novara</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gianluca Gaidano</last_name>
    </contact>
    <investigator>
      <last_name>Gianluca Gaidano</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monia Lunghi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università degli Studi di Padova - Ematologia ed Immunologia Clinica</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renato Zambello</last_name>
    </contact>
    <investigator>
      <last_name>Gianni Binotto</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renato Zambello</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>U.O. di Ematologia con trapianto - Centro di Riferimento Regionale per le coagulopatie rare nel bambino e nell'adulto Dipart. Biomedico di Medicina Interna - A.U. Policlinico &quot;Paolo Giaccone&quot;</name>
      <address>
        <city>Palermo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Enza Mitra</last_name>
    </contact>
    <investigator>
      <last_name>Maria Enza Mitra</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cinzia Maugeri</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cattedra di Ematologia CTMO Università degli Studi di Parma</name>
      <address>
        <city>Parma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Crugnola</last_name>
    </contact>
    <investigator>
      <last_name>Monica Crugnola</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Med. Int. ed Oncologia Medica IRCCS Policlinico S. Matteo</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosangela Invernizzi</last_name>
    </contact>
    <investigator>
      <last_name>Rosangela Invernizzi, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Federica Quaglia, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore</name>
      <address>
        <city>Pesaro</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Visani</last_name>
    </contact>
    <investigator>
      <last_name>Sara Barulli</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giuseppe Visani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>U.O. Ematologia Clinica - Azienda USL di Pescara</name>
      <address>
        <city>Pescara</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Di Bartolomeo</last_name>
    </contact>
    <investigator>
      <last_name>Paolo Di Bartolomeo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza</name>
      <address>
        <city>Piacenza</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Costanza Bosi</last_name>
    </contact>
    <investigator>
      <last_name>Costanza Bosi, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>U.O. di Ematologia - Centro Oncologico Basilicata</name>
      <address>
        <city>Rionero in Vulture</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pellegrino Musto</last_name>
    </contact>
    <investigator>
      <last_name>Pellegrino Musto, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oreste Villani, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complesso Ospedaliero S. Giovanni Addolorata</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanna Fennu</last_name>
    </contact>
    <investigator>
      <last_name>Susanna Fennu</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefania Cortese</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>U.O.C. Ematologia - Ospedale S.Eugenio</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pasquale Niscola</last_name>
    </contact>
    <investigator>
      <last_name>Pasquale Niscola</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Scaramucci</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università Cattolica del Sacro Cuore - Policlinico A. Gemelli</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Livio Pagano, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Livio Pagano, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Teresa Voso, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università degli Studi - Policlinico di Tor Vergata</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adriano Venditti</last_name>
    </contact>
    <investigator>
      <last_name>Adriano Venditti, dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luca Maurillo, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza</name>
      <address>
        <city>S. G. Rotondo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Cascavilla</last_name>
    </contact>
    <investigator>
      <last_name>Nicola Cascavilla</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grazia Sanpaolo, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dipartimento di Oncologia ed Ematologia S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernardino Allione</last_name>
    </contact>
    <investigator>
      <last_name>Stefano D'Ardia</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernardino Allione</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica Ematologica-Centro Trapianti e Terapie cellulari Azienda Ospedaliero-Universitaria, Udine</name>
      <address>
        <city>Udine</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Candoni</last_name>
    </contact>
    <investigator>
      <last_name>Anna Candoni</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erica Simeone</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2013</study_first_submitted>
  <study_first_submitted_qc>September 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2013</study_first_posted>
  <last_update_submitted>February 20, 2018</last_update_submitted>
  <last_update_submitted_qc>February 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adult patients</keyword>
  <keyword>Infective events</keyword>
  <keyword>Antibiotic</keyword>
  <keyword>Antifungal</keyword>
  <keyword>Myelodysplastic syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Myelodysplastic Syndromes</mesh_term>
    <mesh_term>Preleukemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Cephalosporins</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
    <mesh_term>Itraconazole</mesh_term>
    <mesh_term>Antifungal Agents</mesh_term>
    <mesh_term>Miconazole</mesh_term>
    <mesh_term>Posaconazole</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

